IMR Press / RCM / Volume 15 / Issue S1 / 10.3908/ricm15S1S001

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Management of Dyslipidemia in Patients With Human Immunodeficiency Virus
Show Less
1 Swedish Medical Center, Seattle, WA
Rev. Cardiovasc. Med. 2014, 15(S1), 38–46;
Published: 20 January 2014
Dyslipidemias are more common in the patient population with human immunodeficiency virus (HIV). Combination antiretroviral therapy (ART) has dramatically reduced HIV-associated morbidity and mortality and has transformed HIV disease into a chronic, manageable condition. As a result, non–AIDS-related illnesses, including cardiovascular diseases, are now the leading causes of death in the HIV-infected population. Optimizing fasting lipid parameters plays an important role in reducing cardiovascular risk in this population. This review focuses on the management of dyslipidemia in HIV-infected individuals treated with combination ART.
Human immunodeficiency virus
Antiretroviral therapy
Cardiovascular risk
Back to top